Quoin Pharmaceuticals QNRX
NASDAQ QNRX
$4.02 +0.01 (+0.25%)
As of: Oct 23, 2026 · 3:32 PM EDT

Quoin Pharmaceuticals (QNRX) Cash & Current Investments (2016 - 2026)

Updated

Quoin Pharmaceuticals' Cash & Current Investments was $10.85 million in the quarter ended Jun 30, 2026, up 538.0% from $1.7 million a year earlier but down 22.8% from the prior quarter.

Analysis

Quoin Pharmaceuticals (QNRX) Cash & Current Investments (2016 - 2026) Analysis & Trends

As of Dec 31, 2025, Cash & Current Investments at Quoin Pharmaceuticals came in at $18.75 million, up 33.4% from the prior year.

  • Cash & Current Investments shows a five-year compound annual growth rate of 125.2% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Cash & Current Investments was $14.06 million in the year ended Dec 31, 2024 (+485.4%), $2.4 million in the year ended Dec 31, 2023 (-16.1%), $2.86 million in the year ended Dec 31, 2022 (-61.8%) and $7.48 million in the year ended Dec 31, 2021.
  • Quarterly Cash & Current Investments has moved between $1.7 million (the quarter ended Jun 30, 2025) and $18.75 million (the quarter ended Dec 31, 2025) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for three straight quarters, with growth averaging 168.6% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was the quarter ended Jun 30, 2026 (growth of 538.0%); the worst was the quarter ended Dec 31, 2022 (a decline of 61.8%).
  • Per Business Quant data, QNRX's Cash & Current Investments in the three quarters before the quarter ended Jun 30, 2026 was $14.04 million (quarter ended Mar 31, 2026), $18.75 million (quarter ended Dec 31, 2025) and $1.83 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Quoin Pharmaceuticals 325,380.52 -45.14 Mn - 10.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.85 Mn
Mar 31, 2026 14.04 Mn
Dec 31, 2025 18.75 Mn
Sep 30, 2025 1.83 Mn
Jun 30, 2025 1.70 Mn
Mar 31, 2025 3.82 Mn
Dec 31, 2024 14.06 Mn
Sep 30, 2024 3.12 Mn
Jun 30, 2024 2.85 Mn
Mar 31, 2024 1.83 Mn
Dec 31, 2023 2.40 Mn
Sep 30, 2023 3.20 Mn
Jun 30, 2023 4.80 Mn
Mar 31, 2023 3.40 Mn
Dec 31, 2022 2.86 Mn
Sep 30, 2022 5.25 Mn
Jun 30, 2022 2.69 Mn
Dec 31, 2021 7.48 Mn
Dec 31, 2020 5.28 Mn
Jun 30, 2020 7.05 Mn
API Access

Quoin Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=QNRX&period=max&api_key=YOUR_API_KEY